Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.10
-0.09 (-2.82%)
At close: Aug 15, 2025, 12:38 PM

Protara Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
332K 341K 247K 1.17M
Gross Profit
-332K -341K -247K -1.17M
Operating Income
-49.15M -43.61M -67.06M -47.49M
Interest Income
4.13M 2.73M 1.11M 237K
Pretax Income
-44.6M -40.42M -65.95M -47.25M
Net Income
-44.6M -40.42M -65.95M -47.13M
Selling & General & Admin
17.45M 18.62M 20.74M 26.4M
Research & Development
31.7M 24.79M 16.81M 21.09M
Other Expenses
-332K -137K -247K n/a
Operating Expenses
48.82M 43.27M 37.3M 47.49M
Interest Expense
n/a n/a 1.14M 1.74M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
49.15M 43.61M 37.55M 47.49M
Income Tax Expense
n/a n/a -1.14M -117K
Shares Outstanding (Basic)
20.59M 11.33M 11.26M 11.23M
Shares Outstanding (Diluted)
20.59M 11.33M 11.26M 11.23M
EPS (Basic)
-2.17 -3.57 -5.86 -4.2
EPS (Diluted)
-2.17 -3.57 -5.86 -4.2
EBITDA
-49.15M -43.27M -64.57M -46.09M
EBIT
-40.42M -43.61M -64.81M -47.25M
Depreciation & Amortization
-8.73M 341K 247K 1.17M